betacsolol (Q794162)

PubChem ^Saesneg

PubChem CID ^Saesneg

betaxolol (Saesneg)

4 Hydref 2016

C₁₈H₂₉NO₃

1 ffynhonnell

PubChem ^Saesneg

PubChem CID ^Saesneg

betaxolol (Saesneg)

19 Tachwedd 2016

CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O

1 ffynhonnell

PubChem ^Saesneg

PubChem CID ^Saesneg

betaxolol (Saesneg)

https://www.whocc.no/atc_ddd_index/?code=C07AB05

19 Tachwedd 2016

defined daily dose ^Saesneg

20 milligram

dull gweini

gweini genau

1 ffynhonnell

cyfeirnod URL

cynhwysyn actif yn

Betoptic S ^Saesneg

1 ffynhonnell

RxNorm ^Saesneg

RxNorm ID ^Saesneg

215673

14 Chwefror 2018

Betoptic ^Saesneg

1 ffynhonnell

RxNorm ^Saesneg

RxNorm ID ^Saesneg

202369

14 Chwefror 2018

World Health Organisation international non-proprietary name ^Saesneg

betaxolol (Saesneg)

1 ffynhonnell

ChEBI ^Saesneg

ChEBI ID ^Saesneg

betaxolol (Saesneg)

4 Hydref 2016

1 ffynhonnell

NDF-RT ^Saesneg

13 Rhagfyr 2016

1 ffynhonnell

NDF-RT ^Saesneg

13 Rhagfyr 2016

1 ffynhonnell

NDF-RT ^Saesneg

13 Rhagfyr 2016

significant drug interaction ^Saesneg

ferapamil

side effect ^Saesneg

sinus bradycardia ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

sinus bradycardia ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

digocsin

side effect ^Saesneg

sinus bradycardia ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

fingolimod ^Saesneg

side effect ^Saesneg

sinus bradycardia ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

crizotinib ^Saesneg

side effect ^Saesneg

sinus bradycardia ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

ferapamil

side effect ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

diltiasem

side effect ^Saesneg

sinus bradycardia ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

clonidin

side effect ^Saesneg

sinus bradycardia ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

rifastigmin

side effect ^Saesneg

sinus bradycardia ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

methyldopa

side effect ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

diltiasem

side effect ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

terasosin

side effect ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

prasosin

side effect ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

docsasosin mesylad

side effect ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

clonidin

side effect ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

moxonidine ^Saesneg

side effect ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

tamswlosin

side effect ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

alfuzosin ^Saesneg

side effect ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

diltiasem

side effect ^Saesneg

myocardial depression ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

sinoatrial arrest ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

atrioventricular block ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

side effect ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

digocsin

side effect ^Saesneg

toxicity ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

moxonidine ^Saesneg

side effect ^Saesneg

withdrawal hypertension ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

dronedarone ^Saesneg

side effect ^Saesneg

sinus bradycardia ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

fingolimod ^Saesneg

side effect ^Saesneg

decreased heart rate ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

fingolimod ^Saesneg

side effect ^Saesneg

shortened atrioventricular conduction time ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

fingolimod ^Saesneg

side effect ^Saesneg

atrioventricular block ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

disopyramid

side effect ^Saesneg

sinus bradycardia ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

disopyramid

side effect ^Saesneg

methiant y galon

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

disopyramid

side effect ^Saesneg

pulseless electrical activity ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

adweithia'n ffisegol gyda

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

Adrenoceptor beta 1 ^Saesneg

rôl y pwnc

antagonist ^Saesneg

1 ffynhonnell

IUPHAR/BPS Guide to PHARMACOLOGY ^Saesneg

17 Awst 2016

antagonist ^Saesneg

1 ffynhonnell

IUPHAR/BPS Guide to PHARMACOLOGY ^Saesneg

categori beichiogrwydd Awstralia C

17 Awst 2016

categori beichiogrwydd

1 ffynhonnell

mewnforiwyd o

Wicipedia Saesneg

categori beichiogrwydd Unol Daleithiau America C

1 ffynhonnell

mewnforiwyd o

Wicipedia Saesneg

LiverTox likelihood score ^Saesneg

LiverTox toxicity likelihood category E ^Saesneg

1 ffynhonnell

LiverTox ^Saesneg

https://www.ncbi.nlm.nih.gov/books/n/livertox/Betaxolol

8 Ebrill 2021

cyfeirnod URL

last update ^Saesneg

15 Ionawr 2017

1 ffynhonnell

NDF-RT ^Saesneg

5 Mawrth 2018

antihypertensive drug ^Saesneg

1 ffynhonnell

15 Mawrth 2018

Adrenergic beta-1 Receptor Antagonists ^Saesneg

1 ffynhonnell

15 Mawrth 2018

Sympatholytic ^Saesneg

1 ffynhonnell

15 Mawrth 2018

Betaxolol

0 ffynonellau

Identifiers

InChI

InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3

1 ffynhonnell

PubChem ^Saesneg

PubChem CID ^Saesneg

betaxolol (Saesneg)

19 Tachwedd 2016

InChIKey ^Saesneg

2 ffynonellau

PubChem ^Saesneg

PubChem CID ^Saesneg

betaxolol (Saesneg)

19 Tachwedd 2016

ChEBI release 2020-09-01 ^Saesneg

Rhif Cofrestru CAS

63659-18-7

2 ffynonellau

UNII ^Saesneg

betaxolol (Saesneg)

19 Tachwedd 2016

InChIKey ^Saesneg

CAS Common Chemistry ^Saesneg

https://commonchemistry.cas.org/detail?cas_rn=63659-18-7

9 Ebrill 2021

cyfeirnod URL

ChemSpider ID ^Saesneg

2279

1 ffynhonnell

ChemSpider ^Saesneg

ChemSpider ID ^Saesneg

2279

Betaxolol (Saesneg)

19 Tachwedd 2016

PubChem CID ^Saesneg

1 ffynhonnell

PubChem ^Saesneg

PubChem CID ^Saesneg

betaxolol (Saesneg)

19 Tachwedd 2016

Reaxys registry number ^Saesneg

1991268

1 ffynhonnell

ChEBI ^Saesneg

ChEBI ID ^Saesneg

betaxolol (Saesneg)

4 Hydref 2016

ChEBI ID ^Saesneg

mapping relation type ^Saesneg

exact match ^Saesneg

2 ffynonellau

ChEMBL ^Saesneg

ChEMBL ID ^Saesneg

CHEMBL423

BETAXOLOL (Saesneg)

19 Tachwedd 2016

InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3

International Chemical Identifier ^Saesneg

InChI

ChEMBL ID ^Saesneg

CHEMBL423

1 ffynhonnell

ChEMBL ^Saesneg

ChEMBL ID ^Saesneg

CHEMBL423

BETAXOLOL (Saesneg)

seiliwyd ar dybiaethau esboniadol

19 Tachwedd 2016

SureChEMBL ID ^Saesneg

SCHEMBL23530

2 ffynonellau

inferred from InChIKey ^Saesneg

InChIKey ^Saesneg

UniChem compound ID ^Saesneg

398907

1 ffynhonnell

MSBNK-Univ_Connecticut-CO000076

UniChem ^Saesneg

MassBank accession ID ^Saesneg

0 ffynonellau

MSBNK-Univ_Connecticut-CO000077

0 ffynonellau

MSBNK-Univ_Connecticut-CO000078

0 ffynonellau

MSBNK-Univ_Connecticut-CO000079

0 ffynonellau

MSBNK-Univ_Connecticut-CO000080

0 ffynonellau

MSBNK-Waters-WA001968

0 ffynonellau

MSBNK-Waters-WA001969

0 ffynonellau

MSBNK-Waters-WA001970

0 ffynonellau

MSBNK-Waters-WA001971

0 ffynonellau

MSBNK-Waters-WA001972

0 ffynonellau

SPLASH ^Saesneg

splash10-0a4i-1309000000-627420cbd67d8ac1e4ad

0 ffynonellau

splash10-05fr-6900000000-e23f35ab4359c86dd966

0 ffynonellau

splash10-0ab9-9800000000-0fec1fdb5cce29edc7de

0 ffynonellau

splash10-0a6u-9600000000-35b64bf771f1c210f29d

0 ffynonellau

splash10-0900-0619000000-76032f7e5f2fbe405815

0 ffynonellau

DSSTox substance ID ^Saesneg

DTXSID2022674

2 ffynonellau

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Saesneg

InChIKey ^Saesneg

DSSTOX compound identifier ^Saesneg

DTXCID102674

0 ffynonellau

LiverTox ID ^Saesneg

Betaxolol

0 ffynonellau

EC number ^Saesneg

613-310-1

1 ffynhonnell

ECHA Substance Infocard database ^Saesneg

ECHA Substance Infocard ID ^Saesneg

100.113.058

27 Rhagfyr 2018

(3-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-2-hydroxypropyl)(propan-2-yl)amine (Saesneg)

dyfyniad

CAS no.: 63659-18-7 (Saesneg)

ECHA Substance Infocard ID ^Saesneg

100.113.058

1 ffynhonnell

ECHA Substance Infocard database ^Saesneg

ECHA Substance Infocard ID ^Saesneg

100.113.058

27 Rhagfyr 2018

(3-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-2-hydroxypropyl)(propan-2-yl)amine (Saesneg)

dyfyniad

CAS no.: 63659-18-7 (Saesneg)

Cod yr ATC

S01ED02

1 ffynhonnell

Dynodwr Drugbank (Alberta)

DrugBank ^Saesneg

00195

Dynodwr Drugbank (Alberta)

Betaxolol (Saesneg)

17 Tachwedd 2015

1 ffynhonnell

DrugBank ^Saesneg

00195

Betaxolol (Saesneg)

dyddiad cyhoeddi

17 Tachwedd 2015

1 ffynhonnell

IUPHAR/BPS Guide to PHARMACOLOGY ^Saesneg

betaxolol (Saesneg)

19 Tachwedd 2016

Betaxolol

0 ffynonellau

Cod MeSH

D02.033.100.624.698.077

0 ffynonellau

D02.033.755.624.698.077

0 ffynonellau

D02.092.063.624.698.077

0 ffynonellau

RxNorm ID ^Saesneg

1520

1 ffynhonnell

UNII ^Saesneg

betaxolol (Saesneg)

Dynodwr Drugbank (Alberta)

19 Tachwedd 2016

DB00195

1 ffynhonnell

InChIKey ^Saesneg

seiliwyd ar dybiaethau esboniadol

dynodwr HMDB

HMDB0014341

2 ffynonellau

inferred from InChIKey ^Saesneg

InChIKey ^Saesneg

UNII ^Saesneg

2 ffynonellau

UNII ^Saesneg

betaxolol (Saesneg)

19 Tachwedd 2016

InChIKey ^Saesneg

MedlinePlus drug identifier ^Saesneg

0 ffynonellau

eye contact ^Saesneg

0 ffynonellau

NDF-RT

N0000147726

1 ffynhonnell

UNII ^Saesneg

betaxolol (Saesneg)

19 Tachwedd 2016

Probes And Drugs ID ^Saesneg

PD010175

0 ffynonellau

DrugCentral ID ^Saesneg

1 ffynhonnell

UniChem ^Saesneg

1 ffynhonnell

ChEBI ^Saesneg

ChEBI ID ^Saesneg

betaxolol (Saesneg)

4 Hydref 2016

1 ffynhonnell

ChEBI ^Saesneg

ChEBI ID ^Saesneg

betaxolol (Saesneg)

4 Hydref 2016

1 ffynhonnell

Freebase Data Dumps ^Saesneg

dyddiad cyhoeddi

28 Hydref 2013

dynodwr KBpedia

BetaxololHydrochloride

1 ffynhonnell

KBpedia ^Saesneg

dynodwr Microsoft Academic

9 Gorffennaf 2020

2779938033

0 ffynonellau

OpenAlex ID ^Saesneg

1 ffynhonnell

OpenAlex ^Saesneg

26 Ionawr 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

UMLS CUI ^Saesneg

C0005320

1 ffynhonnell

UNII ^Saesneg

betaxolol (Saesneg)